Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,976 | -4,069 | -33,150 | -25,901 | -19,696 |
| Depreciation Amortization | 1,198 | 588 | 1,484 | 889 | 592 |
| Accounts payable and accrued liabilities | -275 | -596 | -2,700 | -2,207 | -1,167 |
| Other Working Capital | 605 | -155 | -4,134 | -3,170 | -2,168 |
| Other Operating Activity | 1,022 | 706 | 4,851 | 3,547 | 2,063 |
| Operating Cash Flow | $-7,426 | $-3,526 | $-33,649 | $-26,842 | $-20,376 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -82 | -34 | -1,405 | -1,151 | -890 |
| Investing Cash Flow | $-82 | $-34 | $-1,405 | $-1,151 | $-890 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 201 | 33,323 | 33,319 | 33,274 |
| Other Financing Activity | 201 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $201 | $201 | $33,323 | $33,319 | $33,274 |
| Exchange Rate Effect | 388 | 7 | -825 | -673 | -383 |
| Beginning Cash Position | 31,768 | 31,768 | 34,324 | 34,324 | 34,324 |
| End Cash Position | 24,849 | 28,416 | 31,768 | 38,977 | 45,949 |
| Net Cash Flow | $-6,919 | $-3,352 | $-2,556 | $4,653 | $11,625 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,426 | -3,526 | -33,649 | -26,842 | -20,376 |
| Capital Expenditure | -82 | -34 | -1,405 | -1,151 | -890 |
| Free Cash Flow | -7,508 | -3,560 | -35,054 | -27,993 | -21,266 |